Eva Baecklund
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
IL40: A Newly Described Cytokine With Conflicting Measurements and Detection Variability-Are There Different Forms?
Journal: Scandinavian journal of immunology
Published: December 18, 2025
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
Journal: Annals of the rheumatic diseases
Published: March 04, 2025
Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13.
Journal: Clinical immunology (Orlando, Fla.)
Published: December 29, 2024
A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren's disease.
Journal: Rheumatology (Oxford, England)
Published: September 22, 2024
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2024
Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 13, 2024
Trigger finger - Poor outcome of surgery associated with younger age, pain, psoriatic arthritis and atopic disease.
Journal: Upsala journal of medical sciences
Published: November 15, 2023
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance.
Journal: Therapeutic advances in musculoskeletal disease
Published: May 12, 2023
Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.
Journal: Nature communications
Published: February 03, 2023
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: December 23, 2022
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.
Journal: Annals of the rheumatic diseases
Published: December 13, 2022
Last Updated: 09/26/2026